FFO
FLGT icon

Fortitude Family Office’s Fulgent Genetics FLGT Stock Holding History

Fortitude Family Office’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.82K Buy
+128
New +$2.57K ﹤0.01% 1860
2025
Q3 		– Sell
-26
Closed -$517 – 2038
2025
Q2 		$517 Buy
+26
New +$507 ﹤0.01% 1795

Other funds holding FLGT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return

Fortitude Family Office's FLGT Position: Q3 2026 in Review

Fortitude Family Office opened a new position in Fulgent Genetics (FLGT) in Q3 2026: 128 shares worth $2.82K. The stake represents ﹤0.01% of the portfolio and ranks #1860 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in FLGT as recently as Q2 2025.

Fortitude Family Office first reported a position in FLGT in Q2 2025 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Fortitude Family Office held 128 shares of Fulgent Genetics worth $2.82K as of Q3 2026.
  • Fulgent Genetics was a new Fortitude Family Office position in Q3 2026.
  • Fulgent Genetics made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1860 holding.
  • Fortitude Family Office first reported a position in Fulgent Genetics in Q2 2025 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.